The reported that there are currently 14 oncology medicines listed "in shortage" by US regulators, and with more than 1 million Americans needing to undergo chemotherapy each year, doctors have begun rationing their supplies.
When the going gets tough, the US discreetly imports Chinese cancer drugs.
As America continues to struggle with a shortage of chemotherapy drugs, the FDA is allowing imports from China of Qilu Pharmaceuticals' cisplatin, despite its drug not having federal approval and the vials being labeled in Chinese, reported this weekend. Roughly 10% to 20% of all cancer patients will take it.
FDA approves shipments from the plant in India as long as a third party certifies their quality.
I guess chemotherapy patients will better have to learn how to read Chinese from now on...